Stereotaxis Inc Share Price Nasdaq
Equities
US85916J4094
Advanced Medical Equipment & Technology
Sales 2024 * | 30.88M 2.46B | Sales 2025 * | 44.25M 3.53B | Capitalization | 189M 15.07B |
---|---|---|---|---|---|
Net income 2024 * | -19M -1.52B | Net income 2025 * | -16M -1.28B | EV / Sales 2024 * | 6.12 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 4.27 x |
P/E ratio 2024 * |
-9.79
x | P/E ratio 2025 * |
-12.3
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.12% |
Latest transcript on Stereotaxis Inc
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 28/09/16 | |
Kimberly Peery
DFI | Director of Finance/CFO | 55 | 31/12/02 |
Laura Garth
LAW | General Counsel | - | 31/12/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Messey
BRD | Director/Board Member | 78 | 30/04/05 |
Chief Executive Officer | 57 | 28/09/16 | |
Nathan Fischel
BRD | Director/Board Member | 68 | 02/02/17 |
1st Jan change | Capi. | |
---|---|---|
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |